Q3 2025 · 13F-HR
North Peak Capital Management, LLCholdings as filed
Filed 2025-11-13 · accession 0001213900-25-109732
$1.14B
Reported value
9
Positions
2025-09-30
Period end
The Brief · North Peak Capital Management, LLC · Q3 2025
AI · grounded in 13F
North Peak Capital Management, LLC established a new position in RSP valued at $260.7M. The fund also initiated new stakes in HGV for $231.8M and CVNA for $180.1M. Other new additions include SCHW at $152.2M, PEGA at $134.9M, and ELV at $81.7M. Total assets under management stand at $1.14B across 9 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 46137V357 | RSP | INVESCO EXCHANGE TRADED FD T | $260.7M | 22.8% | 1,374,131 | PUT | SOLE |
| 43283X105 | HGV | HILTON GRAND VACATIONS INC | $231.8M | 20.3% | 5,544,712 | Common | SOLE |
| 146869102 | CVNA | CARVANA CO | $180.1M | 15.8% | 477,343 | Common | SOLE |
| 808513105 | SCHW | SCHWAB CHARLES CORP | $152.2M | 13.3% | 1,594,496 | Common | SOLE |
| 705573103 | PEGA | PEGASYSTEMS INC | $134.9M | 11.8% | 2,346,501 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC FORMERLY | $81.7M | 7.16% | 252,809 | Common | SOLE |
| 26210V102 | DRVN | DRIVEN BRANDS HLDGS INC | $46.8M | 4.10% | 2,906,954 | Common | SOLE |
| 00857U107 | AGL | AGILON HEALTH INC | $35.5M | 3.11% | 34,424,477 | Common | SOLE |
| 405024100 | HAE | HAEMONETICS CORP MASS | $17.7M | 1.55% | 362,366 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.